Anuh Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE489G01022
NSEID: ANUHPHR
BSEID: 506260

INR

172.50

4.95 (2.95%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.87 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Consolidate Quarterly Results

Mar'16

Mar'15

Net Sales

68.41

70.42

Other Operating Income

1.73

1.00

Total Operating income

70.14

71.42

Raw Material Cost

42.33

48.21

Purchase of Finished goods

2.28

1.15

(Increase) / Decrease In Stocks

9.08

7.47

Employee Cost

1.60

1.45

Power Cost

0.48

0.77

Manufacturing Expenses

7.99

4.51

Selling and Distribution Expenses

0.00

Other Expenses

0.11

0.58

Total Expenditure (Excl Depreciation)

63.86

64.15

Operating Profit (PBDIT) excl Other Income

6.28

7.27

Other Income

1.29

1.48

Operating Profit (PBDIT)

7.57

8.75

Interest

0.03

Exceptional Items

0.00

Gross Profit (PBDT)

7.54

8.72

Depreciation

0.57

1.87

Profit Before Tax

6.97

6.85

Tax

1.83

1.87

Provisions and contingencies

0.00

Profit After Tax

5.14

4.98

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

5.14

4.98

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

0.00

Equity Capital

12.53

4.18

Face Value

5.0

Reserves

0.00

Earnings per share (EPS)

2.05

1.99

Diluted Earnings per share

2.05

5.97

Operating Profit Margin (Excl OI)

8.95%

10.18%

Gross Profit Margin

10.75%

12.21%

PAT Margin

7.32%

6.98%

Public Share Holdings (%)

0.0%

35.01%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is -3.88% vs 20.33% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -31.25% vs 58.15% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is -12.39% vs 59.60% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is 75.00% vs 14.29% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Anuh Pharma With

Select Peers

Figures in Rs cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

68.41

3,230.00

-3,161.59

-97.88%

Other Operating Income

1.73

0.00

1.73

Total Operating income

70.14

3,230.00

-3,159.86

-97.83%

Raw Material Cost

42.33

536.11

-493.78

-92.10%

Purchase of Finished goods

2.28

387.30

-385.02

-99.41%

(Increase) / Decrease In Stocks

9.08

11.81

-2.73

-23.12%

Employee Cost

1.60

709.71

-708.11

-99.77%

Power Cost

0.48

0.00

0.48

Manufacturing Expenses

7.99

0.00

7.99

Selling and Distribution Expenses

0.00

Other Expenses

0.11

755.27

-755.16

-99.99%

Total Expenditure (Excl Depreciation)

63.86

2,400.20

-2,336.34

-97.34%

Operating Profit (PBDIT) excl Other Income

6.28

829.80

-823.52

-99.24%

Other Income

1.29

77.32

-76.03

-98.33%

Operating Profit (PBDIT)

7.57

907.12

-899.55

-99.17%

Interest

0.03

220.93

-220.90

-99.99%

Exceptional Items

0.00

Gross Profit (PBDT)

7.54

686.19

-678.65

-98.90%

Depreciation

0.57

192.30

-191.73

-99.70%

Profit Before Tax

6.97

497.33

-490.36

-98.60%

Tax

1.83

112.81

-110.98

-98.38%

Provisions and contingencies

0.00

Profit After Tax

5.14

381.08

-375.94

-98.65%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

5.14

381.08

-375.94

-98.65%

Share in Profit of Associates

0.00

3.44

-3.44

-100.00%

Minority Interest

0.00

4.29

-4.29

-100.00%

Other related items

0.00

Consolidated Net Profit

0.00

380.23

-380.23

-100.00%

Equity Capital

12.53

40.06

-27.53

-68.72%

Face Value

5.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.05

9.49

-7.44

-78.40%

Diluted Earnings per share

2.05

9.44

-7.39

-78.28%

Operating Profit Margin (Excl OI)

8.95%

25.69%

0.00

-16.74%

Gross Profit Margin

10.75%

21.24%

0.00

-10.49%

PAT Margin

7.32%

11.90%

0.00

-4.58%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 159.51 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -3.88% vs 20.33% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -7.32% vs 24.05% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 10.34 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -31.25% vs 58.15% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -45.89% vs 105.26% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 14.78 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -12.39% vs 59.60% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -38.39% vs 93.00% in Dec 2023

Quarterly - Interest

Interest 0.28 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 75.00% vs 14.29% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 100.00% vs 366.67% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 9.27%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023